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Summary. An indirect immunofluorescence t chnique, 
using murine monoclonal antibodies (MoAbs) against 
human IFN-~ and human IFN-? was used to study IFNs 
in cryostat sections from psoriatic skin lesions. The 
IFNs were more pronounced in sections from highly 
active psoriasis than in sections from stationary pso- 
riasis. In highly active psoriatic lesions IFN-~ was 
localized to keratinocytes is stratum basale, to some 
epidermal dendritic cells, probably Langerhans cells, 
and to some mononuclear cells in dermis. IFN-~ was 
usually not detected in sections from stationary pso- 
riasis. IFN-y was localized to stratum corneum, to 
keratinocytes around microabcesses and to mononn- 
clear cells in the dermal cell infiltrates, predominantly 
in highly active psoriatic lesions. Both IFN-~ and IFN- 
were localized to some endothelial cells in the papillary 
dermis. The MoAbs did not stain sections from unaffec- 
ted skin from patients with psoriasis or sections from 
healthy individuals. The findings indicate that the IFN 
system in the skin may be of significance in the patho- 
physiology of psoriasis. 
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Previously, we demonstrated interferon (IFN) in 
serum and suction blister fluid from patients with 
psoriasis using an infectivity inhibition micromethod 
[4]. Sera from patients with psoriasis had higher levels 
of IFN than sera from healthy individuals. Higher 
IFN levels were detected in suction blister fluid from 
psoriatic skin lesions than in serum and in suction 
blister fluid from unaffected skin, indicating IFN pro- 
duction in the skin lesions. Characterization exper- 
iments indicated the presence of IFN-7 and both acid 
labile and acid stable IFN-a in blister fluids and sera. 
Extended studies using an ELISA assay indicate in- 
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creased levels of IFN-? in sera from patients with 
active psoriasis compared with sera from healthy indi- 
viduals, while sera from patients with stationary pso- 
riasis have decreased levels of IFN-7 (unpublished 
data). Recently, Kapp et al. [11] found decreased IFN 
production by peripheral eukocytes from patients 
with psoriasis. 
IFN-7 is mainly produced by activated T lympho- 
cytes, whereas IFN-~ is produced by several cell types 
after various viral and nonviral stimuli. Previously, 
we demonstrated retrovirus-like particles in suction 
blister fluids from psoriatic skin lesions [5]. The pres- 
ence of IFN-a and retrovirus-like particles in blister 
fluids from psoriatic lesions indicated that virus may 
be of significance in the pathogenesis of psoriasis [23]. 
Further information on IFN in psoriasis is of par- 
ticular interest in relation to disease activity and cellu- 
lar localization. Therefore, we examined sections of 
psoriatic and normal skin using an immuno- 
fluorescence t chnique with monoclonal antibodies to 
human IFN-~ and IFN-~. 
Materials and methods 
Patients and tissue 
Skin biopsy specimens were obtained from 5 patients with 
stationary psoriasis, from 5 patients with highly active peripher- 
ally spreading psoriasis (average age, 46 years) and from 10 
healthy individuals (average age, 32 years). Punch biopsy speci- 
mens (6 ram) were taken from margins of fully developed lesions 
and from unaffected skin at least 10.cm from visible lesions. 
Local treatment was interrupted for at least 1 week before the 
biopsy specimens were taken and none of the patients received 
systemic treatment. Punch biopsies (3 mm) from healthy individ- 
uals were obtained from the same areas as biopsies from the 
psoriaties. All tissue samples were washed for 10 rain in phospha- 
te buffered saline (PBS), pH 7.2, snap-frozen i isopentane pre- 
chilled to -140~ in liquid nitrogen, and stored at -70~ 
Cryostat sections were cut at 4 -6  gm. 
Antibodies and sera 
A murine monoclonal ntibody (MoAb; IgGl) against human 
IFN-~ was purchased from Hybritech, San Diego, Calif., USA, 
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and a murine MoAb (IgG2) against human IFN-y was purchased 
from Chemicon, Los Angeles, Calif., USA. MoAb Leu6 (anti- 
CDla), reacting with epitopes on Langerhans cells, was pur- 
chased from Becton Dickinson Laboratory Systems, Mountain 
View, Calif., USA. Fluorescein isothiocyanate (FITC)-conju- 
gated rabbit anti-mouse IgG (RAMIgG) and FITC~conjugated 
goat anti-rabbit IgG (GARIgG), purchased from DAKO 
Immunoglobulins, Copenhagen, Denmark, were used for detec- 
tion of the reaction of the primary antibodies. Pooled native 
human IgG (Fraction II, 16.5% solution) was purchased from 
Kabi, Stockholm, Sweden. Normal mouse serum was provided 
from the local animal unit. Before use the preparations were 
centrifuged atI00,000 g for ! h to remove aggregates. 
Immunofluoresence te hnique 
Unfixed cryostat sections were incubated with MoAbs at 4~ 
overnight (24 h) in a moist chamber. In some experiments he 
MoAbs were diluted in PBS-containing human IgG (8 mg/ml) 
to prevent binding to receptors for the Fc part of IgG [13]. 
Preliminary experiments showed that the anti-IFN-c~ antibody 
stained sections of active psoriasis up to a dilution of I in 4096, 
and the anti IFN-y antibody up to a dilution of 1 in 1024. In 
further experiments he anti-IFN-c~ was used diluted 1 in 1024 
and the anti tFN-y diluted 1 in 256 if not otherwise stated. The 
anti-CD 1 a MoAb was used diluted 1 in 2048. The sections were 
then washed in PBS, incubated for 45 rain with FITC-conjugated 
RAMIgG diluted 1 in 32 in PBS containing 25% pooled human 
serum. Finally, the sections were washed in PBS and incubated 
for 45 rain with FITC-conjugated GARIgG diluted I in 32 in 
PBS containing 25% pooled human serum. The sections were 
then washed in PBS and mounted in PBS and glycerol. Control 
sections were incubated with PBS or mouse serum diluted 1 in 
16 in PBS in the first step and further incubated as described. 
The sections were examined in a Leitz Orthoplane micro- 
scope quipped with a Ploemopak for incident light fluorescence, 
using a 150 W Xenon lamp and filters L2 or K2. Photomicro- 
graphs were taken with a Leitz Varioorthomat camera and 
Kodak Tri X (400 ASA black and white) film. 
Results 
The MoAb against IFN-e stained cells both in epider- 
mis and dermis in highly active psoriatic lesions 
characterized by spongiosis and microabscesses in 
stratum corneum. In the epidermis the staining was 
localized to keratinocytes in the basal ayer. The stain- 
ing was granular and showed two main patterns, one 
mainly localized to the outer aspect of the keratino- 
cytes, the other mainly localized to the nuclei and 
diffusely in the cytoplasm (Fig. 1 a). The keratinocytes 
in stratum spinosum and in stratum corneum were not 
stained. The intensity and staining pattern varied from 
one area to another in the same section, and in sections 
from different patients. The keratinocytes in sections 
from stationary psoriasis were not stained. The MoAb 
also gave a strong intracellular staining of some epi- 
dermal dendritic cells (Fig. 1 b). The morphology of 
the dendritic cells corresponded to and had similar 
distribution as the CDla+ cells. The number of cells 
stained by the MoAb against IFN-e was, however, 
lower than the number of CD 1 a + cells. In the dermis 
the IFN-e antibody gave a granular staining of the 
cell membranes of some mononuclear cells (Fig.1 b) 
and of the cytoplasm of some endothelial cells in the 
papillary dermis (Fig. 1 c). In sections from stationary 
psoriasis the staining of dendritic ells and mononu- 
clear cells was weak to negative. 
Sections from unaffected skin from patients with 
highly active psoriasis, sections from unaffected skin 
from patients with psoriasis vulgaris, and sections 
from normal skin were not stained with the MoAb 
against IFN-e even at a dilution of 1 in 16 (Fig. 1 d). 
The MoAb against IFN-y gave a strong laminar 
staining of stratum corneum in sections from highly 
active and a weaker staining in sections from station- 
ary psoriasis (Fig. 2a). Stratum corneum in sections 
from unaffected skin from patients with psoriasis and 
in sections from normal skin were only occasionally 
stained. The cell membranes of keratinocytes around 
microabscesses were also stained, whereas cells in 
stratum basale and stratum spinosum were not. In the 
dermis the IFN-7 antibody gave a strong granular 
staining of cells in the mononuclear cell infiltrates in 
sections from highly active psoriasis (Fig. 2 b) and a 
weaker staining in sections from stationary psoriasis 
apparently localized to the cell membranes. Staining 
was also seen in the cytoplasm of some endothelial 
cells in the papillary dermis. The MoAb did not stain 
dermal cells in sections from unaffected skin from 
patients with psoriasis nor dermal cells in sections 
from normal skin. 
Control sections incubated with PBS or normal 
mouse serum diluted 1 in 16 were all negative (Fig. 2c). 
Discussion 
In the present study, IFN-e and IFN-;~ were demon- 
strated on various cell types in highly active psoriasis 
lesions. In lesions from stationary psoriasis IFN-7 
could be detected whereas IFN-c~ were only occasion- 
ally present. The demonstration of IFN mainly in 
highly active psoriasis accords with the results recently 
reported by Traugott and Lebon [29]. They found IFN 
on various cell types in active multiple sclerosis (MS) 
lesions, but not on cells in inactive chronic MS lesions. 
Furthermore, Jilbert et al. [10] demonstrated IFN on 
cells in chronic active hepatitis but only occasionally 
on cells in chronic persistent hepatitis. The present 
data obtained could be due to a possible cross-reaction 
of the MoAbs with epitopes on other molecules than 
IFNs. This is, however, unlikely since the MoAbs did 
not react with sections from unaffected skin from 
patients with psoriasis or sections from normal skin. 
Recently, Yaar et al. [33] could not detect IFN-e in 
sections from normal epidermis using three different 
MoAbs. 
Fig. 1 a -  d. Sections of highly active psoriasis stained with the 
MoAb against IFN-c~. a Staining mainly ocalized to the nuclei 
and cytoplasm of keratinocytes in the basal layer (dotted line, 
basement membrane zone; x 530); b staining localized to den- 
dritic cells in stratum spinosum (arrow) and to mononuclear 
cells in the papillary dermis (arrowhead; dotted line, basement 
membrane zone; x 470); e staining localized to endothelial cells 
in the papillary dermis (open arrow; x 300); d section from 
unaffected skin from a patient with highly active psoriasis. No 
staining ( x 250) 
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Fig. 2a -c .  Sections from stationary psoriasis tained with the 
MoAb against human IFN-~. a Staining localized to stratum 
corneum ( x 250); b staining localized to mononuclear cells in 
the dermal cell infiltrates ( x 280); c section incubated with PBS 
in the first step. No staining ( x 250) 
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The expression of IFN-e by basal keratinocytes, 
epidermal dendritic ells, mononuclear cells and by 
endothelial cells may indicate that the cells have been 
stimulated to produce IFN. This may be due to a virus 
infection [7, 21]. Whether these cells are virus-infected 
is at present unknown, but our demonstration f virus- 
like particles [5] in suction blister fluid from psoriatic 
lesions is intriguing. Alternatively, IFN-e in these cells 
may be due to IFN-inducing molecules present as a 
result of the mononuclear celt infiltrate. IFN- 7 has 
been shown to trigger the production of IFN-c~ [12]. 
IFN-c~ may therefore be induced by IFN-7 diffusing 
from the IFN-7-positive mononuclear cells. The 
marked expression of IFN-~ in stratum corneum does 
in fact support he assumption that IFN-7 may diffuse 
through the epidermis. The data do not, however, 
exclude the possibility that the presence of IFN-e in 
these cells is due to receptor-mediated en ocytosis of 
IFN-a produced by other cell types. According to 
Grossberg et al. [9] membrane-bound IFN are rapidly 
processed by receptor-mediated ndocytosis into 
coated vesicles and receptosomes which then empty 
into the perinuclear space. IFN molecules are then 
seen adjacent to or in nuclear pores and within the 
nucleus, primarily in dense chromatin. The staining 
pattern of the basal keratinocytes may therefore indi- 
cate that IFN-c~ present in these cells is due to 
endocytosis. In contrast, the diffuse staining within 
the cytoplasm of epidermal dendritic ells, mononu- 
clear and endothelial cells makes it unlikely that IFN- 
detected was due to endocytosis [10]. Whether the 
IFNs detected inpsoriatic lesions are produced locally 
is uncIear. However, our previous data obtained study- 
ing IFNs in serum and suction blister fluid indicated 
a local production of IFN [4]. 
The strong expression of IFN-7 by the mononu- 
clear cells sustained our previous assumption that 
these cells are activated [3]. IFN-y-positive mononu- 
clear cells have also been demonstrated in lesions of 
active chronic MS [29]. The expression of IFN in some 
of the endothelial ceils in highly active psoriasis also 
accords with the data reported by Traugott and Lebon 
[29] when studying IFNs in MS. They found that 
endothelial cells in active MS lesions were occasionally 
positive for all three IFN types. According to Pober 
et al. [19], HLA-DR expression by vascular endo- 
thelium is inducible by human IFN-y. The expression 
of IFN-? on endothelial cells is therefore of interest in 
relation to our previous demonstration f HLA-DR 
antigen and receptors for the Fc part of IgG (FcR) on 
endothelial cells in psoriatic skin lesions [6]. 
Recently, we demonstrated FcR on keratinocytes 
in normal and psoriatic skin [13]. Enhanced FcR ac- 
tivity by keratinocytes was found in psoriatic skin 
lesions compared with normal skin and strongest 
above areas with mononuclear cell infiltrates. This was 
of interest in relation to our previous demonstration f 
IFN-7 in suction blister fluid from psoriatic lesions [4], 
as IFN-y can induce or enhance the expression of FcR 
[30]. We assumed that the increased FcR expression by 
keratinocytes was mediated by IFN locally produced. 
The present demonstration f IFN-7 positive cells is 
in favor of this assumption. 
In several cutaneous disorders such as lichen 
planus [27], cutaneous T-cell tymphoma [28], allergic 
contact dermatitis [15], and lupus erythematosus [1]
keratinocytes have been shown to express HLA-DR 
antigens. The keratinocyte c ll-surface HLA-DR ex- 
pression isparticularly seen overlying adermal inflam- 
matory infiltrate consisting largely of T lymphocytes. 
Regulatory interactions beween IFNs and interleukins 
are of importance inskin diseases involving T lympho- 
cytes [18]. It has been shown that interleukin-I ( L-1), 
produced by keratinocytes, induces T lymphocytes to
produce IL-2 which then induces the production of 
IFN- 7 by T lymphocytes [24]. IFN-y produced by 
activated T lymphocytes, is capable of stimulating 
HLA-DR synthesis by keratinocytes [2, 16]. It has 
therefore been postulated that IFN-y produced by the 
dermal T cells and diffusing into epidermis i respon- 
sine for the cell-surface xpression of HLA-DR in 
these disorders. Accordingly, the demonstration of
IFN-7 on cells in the dermal cell infiltrate and in 
stratum corneum is of particular interest. However, 
HLA-DR expression on keratinocytes i  more in- 
frequently found in psoriatic lesions than in other 
inflammatory skin lesions [26]. The reason for this is 
presently unknown. A number of substances, how- 
ever, have been shown to antagonize the induction of 
HLA-DR expression by IFN-7. These include prosta- 
glandins [22], cyclic AMP [35], LPS [35], immune 
complexes [31], c~-fetoprotein [14], serotonium [25], 
and glucocorticosteroids [32]. In addition IFN-c~ has 
been shown to decrease the level of HLA-DR specific 
mRNA [8]. The presence of IFN-e in the basal 
keratinocytes and in epidermal dendritic cells may 
therefore influence the HLA-DR expression i duced 
by IFN-7. According to Yasutaka et al. [34] cross- 
linking of FcR on various cell lines in vitro inhibited 
the ability of IFN-7 to induce HLA-DR. An in vivo 
cross linking of FcR on keratinocytes [13] may there- 
fore be another explanation for the reduced expression 
of HLA-DR on keratinocytes in psoriatic lesions. 
The significance of IFNs in the pathogenesis of
psoriasis is unclear. However, due to their multiple 
biological effects the IFNs may be of importance inthe 
pathophysiology of psoriasis. The strong expression of 
IFNs by different cell types in highly active psoriasis, 
the observation that treatment with recombinant- 
DNA-derived IFN-c~ ("Roferon-A") [20] caused ex- 
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acerbat ion or induced onset of  psoriasis as well as the 
beneficial effect o fcyc lospor in  A, which may be due to 
its inhibi tory effect on IFN-;~ product ion  [17], sustain 
such a hypothesis.  Fur thermore ,  the demonstrat ion  of
IFN-e  in psor iat ic  lesions may support  he hypothesis  
of  a virus et iology in psoriasis. A more  detai led study 
o f  the skin IFN  system will undoubted ly  increase our  
understanding o f  the pathophys io logy  o f psoriasis. 
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